These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32515802)

  • 61. An overview of potential therapeutic agents to treat COVID-19.
    Dong X; Tian Z; Shen C; Zhao C
    Biosci Trends; 2020 Nov; 14(5):318-327. PubMed ID: 33100290
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dexamethasone nanomedicines for COVID-19.
    Lammers T; Sofias AM; van der Meel R; Schiffelers R; Storm G; Tacke F; Koschmieder S; Brümmendorf TH; Kiessling F; Metselaar JM
    Nat Nanotechnol; 2020 Aug; 15(8):622-624. PubMed ID: 32747742
    [No Abstract]   [Full Text] [Related]  

  • 63. Are there any Therapeutic Options Currently Available for Wuhan Coronavirus?
    Carradori S
    Antiinflamm Antiallergy Agents Med Chem; 2020; 19(2):85-87. PubMed ID: 32213152
    [No Abstract]   [Full Text] [Related]  

  • 64. Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19.
    Buschard K
    Med Hypotheses; 2020 Oct; 143():110127. PubMed ID: 32759008
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.
    Caly L; Druce JD; Catton MG; Jans DA; Wagstaff KM
    Antiviral Res; 2020 Jun; 178():104787. PubMed ID: 32251768
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Teicoplanin: an alternative drug for the treatment of COVID-19?
    Baron SA; Devaux C; Colson P; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2020 Apr; 55(4):105944. PubMed ID: 32179150
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs.
    Jeon S; Ko M; Lee J; Choi I; Byun SY; Park S; Shum D; Kim S
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366720
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19.
    Husain A; Byrareddy SN
    Chem Biol Interact; 2020 Nov; 331():109282. PubMed ID: 33031791
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Traditional Chinese medicine for COVID-19 treatment.
    Ren JL; Zhang AH; Wang XJ
    Pharmacol Res; 2020 May; 155():104743. PubMed ID: 32145402
    [No Abstract]   [Full Text] [Related]  

  • 71. N-acetylcysteine as a potential treatment for COVID-19.
    Jorge-Aarón RM; Rosa-Ester MP
    Future Microbiol; 2020 Jul; 15():959-962. PubMed ID: 32662664
    [No Abstract]   [Full Text] [Related]  

  • 72. Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2.
    Tripathi PK; Upadhyay S; Singh M; Raghavendhar S; Bhardwaj M; Sharma P; Patel AK
    Int J Biol Macromol; 2020 Dec; 164():2622-2631. PubMed ID: 32853604
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 74. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sofosbuvir as a potential option for the treatment of COVID-19.
    Nourian A; Khalili H
    Acta Biomed; 2020 May; 91(2):236-238. PubMed ID: 32420958
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?
    Sargin G; Yavaşoğlu Sİ; Yavasoglu I
    Med Hypotheses; 2020 Jul; 140():109756. PubMed ID: 32344306
    [No Abstract]   [Full Text] [Related]  

  • 77. SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
    Magro G
    Travel Med Infect Dis; 2020; 37():101685. PubMed ID: 32334088
    [No Abstract]   [Full Text] [Related]  

  • 78.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis.
    Tong TRS
    Infect Disord Drug Targets; 2020; 20(3):351. PubMed ID: 32696730
    [No Abstract]   [Full Text] [Related]  

  • 80. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.
    South AM; Tomlinson L; Edmonston D; Hiremath S; Sparks MA
    Nat Rev Nephrol; 2020 Jun; 16(6):305-307. PubMed ID: 32246101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.